Search by Drug Name or NDC

    NDC 52083-0655-01 G-Supress DX 5; 50; 2.5 mg/mL; mg/mL; mg/mL Details

    G-Supress DX 5; 50; 2.5 mg/mL; mg/mL; mg/mL

    G-Supress DX is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by KRAMER NOVIS. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 52083-0655
    Product ID 52083-655_a7a9c734-51f2-4396-bad0-0da368adcd75
    Associated GPIs 43997303100940
    GCN Sequence Number 040290
    GCN Sequence Number Description guaifen/dextromethorphan/PE DROPS 50-5-2.5/1 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 53092
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Brand
    Proprietary Name G-Supress DX
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 5; 50; 2.5
    Active Ingredient Units mg/mL; mg/mL; mg/mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name KRAMER NOVIS
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 52083-0655-01 (52083065501)

    NDC Package Code 52083-655-01
    Billing NDC 52083065501
    Package 30 mL in 1 BOTTLE (52083-655-01)
    Marketing Start Date 2011-03-29
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 5dd44337-f3aa-4e73-a206-4a29850a2f7c Details

    Revised: 10/2022